Syra Health Corp.
SYRA
$0.3401
-$0.0189-5.27%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 14.40% | 12.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.40% | 12.41% | |||
| Cost of Revenue | -2.14% | 2.96% | |||
| Gross Profit | 90.94% | 95.20% | |||
| SG&A Expenses | -28.25% | 8.40% | |||
| Depreciation & Amortization | 46.55% | 39.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.17% | 5.12% | |||
| Operating Income | 69.15% | 3.71% | |||
| Income Before Tax | 69.97% | 3.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 69.97% | 3.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 69.97% | 3.93% | |||
| EBIT | 69.15% | 3.71% | |||
| EBITDA | 70.62% | 4.08% | |||
| EPS Basic | 72.70% | 5.48% | |||
| Normalized Basic EPS | 72.72% | 5.46% | |||
| EPS Diluted | 72.70% | 5.48% | |||
| Normalized Diluted EPS | 72.72% | 5.46% | |||
| Average Basic Shares Outstanding | 10.03% | 1.65% | |||
| Average Diluted Shares Outstanding | 10.03% | 1.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
